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1571 ABSTRACT 
A subgenomic promoter of a positive strand RNA virus is 
disclosed which directs the amplified expression of a struc- 
tural gene in plant tissue. The core region and an upstream 
activating domain of the subgenomic promoter are identi- 
fied. This promoter can be utilized in a modified virus, or in 
an appropriate engineered recombinant DNA derivative, 
which may be chromosomally integrated or maintained as an 
episome in transformed cells. 
7 Claims, 8 Drawing Sheets 
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1 
SUBGENOMIC PROMOTER 
This is a continuation of application Ser. No. 081197,222, 
filed Feb. 16, 1994, now abandoned, which is continuation 
of application Ser. No. 081069,457, filed Jun. 1, 1993, now 5 
abandoned, which is a continuation of application Ser. No. 
071683,516, filed Apr. 8, 1991, now abandoned, which is a 
continuation of application Ser. No. 071168,691. filed Mar. 
16,1988, now abandoned, and a continuation-in-part of Ser. 
No. 071368,939, filed Jun. 19, 1989, now abandoned, which 10 
is continuation of Ser. No. 061709,181, filed Mar. 7, 1985, 
now abandoned. 
FIELD OF THE INVENTION 
15 
The field of this invention is the area of molecular 
biology, and it relates in particular to the field of (+) strand 
RNA viruses. The teachings of the present invention will 
enable the use of a viral control sequence, termed a subge- 
nomic promoter, for directed gene expression in the appro- 20 
priate cell host. Specifically, the subgenomic promoter of 
RNA3 of brome mosaic virus is exemplified to amplify the 
expression of a structural gene in plant tissue. 
The plant (+) strand RNA viruses have been classified into 
two supergroups (R. Goldbach (1986) Ann. Rev. Phyto- 
pathol. 24:289). The picomavirus-like supergroup includes 
comoviruses, nepoviruses, and polyviruses, while the sec- 
ond supergroup includes those viruses which resemble the 
animal alphavirus Sindbis virus: the tobamoviruses, tobravi- 
ruses, bromoviruses, cucurnoviruses, and alfalfa mosaic 
virus. Although the (+) strand RNA viruses of plants and 
animals are diverse with respect to host range, genome and 
particle structures, and exact mechanisms of viral replica- 
tion, there are some amino acid and nucleic acid sequence 
homologies (reviewed in R. Goldbach (1987) Microbiol. 
Sci. 4:197). Amino acid sequence homologies have been 
described for poliovirus, foot-and-mouth disease and cow- 
pea mosaic viruses (H. Franssen et al. (1984) EMBO 
J.3:855), and for nonstructural proteins encoded by brome 
mosaic virus, alfalfa mosaic virus, tobacco mosaic virus and 
Sindbis virus (J. Haseloff et al. (1984) Proc. Nat. Acad. Sci. 
USA 81:4358; P. Ahlquist et al. (1985) J. Virol. 53536). The 
homologous regions within the nonstructural proteins are 
believed to reflect mechanistic similarities in the replication 
of viral nucleic acid and possibly evolutionary relationships. 
The alphaviruses and the Sindbis-like plant viruses also 
share a common strategy for synthesis of coat protein (and 
BACKGROUND OF THE INVENTION 25 in some cases for the synthesis of additional prokin(s). That strategy is the use of an internal promoter to direct the 
Single-stranded RNA viruses which are capable of repli- synthesis of ha (+) strand RNA moiecu~e, called a subge- 
cating in the cytoplasm of host cells are widespread in nomic RNA, using the (-1 strand as template. The subge- 
nature. Those single-stranded viruses with message-sense nomic RNA comprises a subset of sequences found in the 
genomic RNA molecules are called (+) strand, or positive 30 corresponding "genomic" (full-length) M A 9  and may be 
strand, RNA viruses. Among the known (+) strand RNA encapsidated in viral particles. In the case of the brome 
viruses there are bacteria-specific, animal-specific, and mosaic virus (BMV), (+) strand RNA molecules outnumber 
plant-specific varieties. There is much diversity in the mor- the full-length (-1 strand template about 100 to 1, and 
phology of virus particles, coat proteins, genetic organiza- subgenomic and full-length genomic RNAs are made in 
tion, and genome size. The (+) strand RNA viruses include, 35 approximately equimolar an~ounts (French and Ahlquist 
but are not limited to, Q-beta bacteriophage, poliovirus and (1987) J. Viral. 61:1457). The subgenomic mRNA, which in 
alphaviruses (including Sindbis virus) of animal cells, and BMV carries only the message for coat protein, is very 
the bromoviruses (including brome mosaic virus) and the effectively translated by the cellular protein synthetic 
comoviruses (including cucumber mosaic virus) of plants. machine~y. For example, gram quantities of BMV-infected 
A general review of (+) strand virus replication has been 40 plant tissue synthesize milligram amounts of coat protein (L. 
published (E. straUss and J. straUss (1983) T ~ ~ .  Lane (1981) in Handbook of Plant Virus Infections and 
~ ~ ~ ~ ~ b i ~ ~ .  Immunol. 105:1). A ~ ~ i ~ f  summary of the steps Comparative Diagnosis, E. Kurstak, Ed., ElsevierNorth- 
follows. Virally determined proteins may be required H011and9 pp.333-376). 
together with the genomic RNA(S) for infection to occur, or The bromoviruses are a group of (+) strand plant viruses 
all the viral proteins required to initiate virus replication may 45 with tripartite genomes. Included in this grouping are brome 
be synthesized using the incoming viral genomic RNA as mosaic V ~ S ,  Cowpea chlorotic mosaic virus (CCMV), and 
message. There is no DNA intermediate in the replication of broadbean mosaic virus (BBMV). CCMV and BBMV infect 
the nucleic acid of these viruses; the replication of the the dicots cowpeas and broadbeans respectively, and the host 
genetic infomation of a (+) strand RNA virus requires the range of BMV is the grasses, including the cereals (L. C. 
RNA-dependent RNA synthetic capability of cells infected 50 Lane7 (1981) in The Handbook of Plant Virus Infections and 
with such viruses. The incoming genomic (+I strand serves Comparative Diagnosis, Chapter 12, Elsevier, Amsterdam). 
as template for the synthesis of (-) strand molecules, and Barley is a Common experimental host for BMV, which has 
then progeny (+) strands are synthesized using the (-) been well characterized. 
strands as templates. At the latter step there is an amplifi- BMV strain M1 (Madison 1) (P. Ahlquist et al. (1984) 
cation of (+) strands over (-) strand molecules. The (+) 55 Proc. Nat. Acad. Sci. USA 81:7066) is the experimental 
strand viral RNA molecule(s) are generally translated, at system chosen to exemplify the present invention. The BMV 
least in part, to yield virus-specific replicase. The (-) strands genome is composed of three RNA molecules of unique, 
serve as the templates for subsequent synthesis of large known sequence: RNAl is 3234 bases in length, RNA2 is 
numbers of (+) strands which may cany structural genes and 2865 bases in length (P. Ahlquist et al. (1984) J. Mol. Biol. 
which are destined to become encapsidated by coat protein. 60 172:369), and RNA3 is about 2114 bases in length (P. 
Structural proteins are translated from genomic RNA or Ahlquist et al. (1981) J. Mol. BioI. 153:23). Complete cDNA 
from subgenomic RNA, depending on the virus. In the clones have been produced (P: Ahlquist and M. Janda (1984) 
instance of the (+) strand viruses with multicomponent RNA Mol. Cell. Biol. 4:2876). RNAs 1 and 2 are individually 
genomes, the RNA molecules may be encapsidated in sepa- encapsidated; RNA3 is encapsidated together with RNA4, 
rate viral particles, in which case the host cell must be 65 the 876 base subgenomic coat protein message which is 
simultaneously infected with each component to yield a presumed not to replicate in vivo (T. Lane (1974) Adv. Virus 
productive infection. Res. 19:151). RNA molecules purified from virus particles 
5,466,788 
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and transcripts prepared from cloned viral cDNA sequences by Miller et al. (1985) and those by Marsh et al. (1987) 
are infectious in the barley protoplast model system (P. utilized in vitro expression experiments to examine the 
Ahlquist et al. (1984) Proc. Nat. Acad. Sci. USA 81:7066). requirements of transcription; their results did not indicate 
Therefore the full range of molecular biological techniques that nucleotide sequence information as far upstream as -95 
is available for the analysis of BMV nucleic acid functional 5 could contribute to the level of (+) strand m m A  synthesis. 
sequences. Neither Miller et al. (1985) nor Marsh et al. (1987) reported 
Experimental manipulations of the cloned BMV genome activity of subgenomic transcription, since in their con- 
have begun to define regions of functional importance (P. structs, sequences 5' to the putative promoter were missing. 
Ahlquist and R. French (1988) in Domingo, Holland and No published study has described the use of a subgenomic 
Ahlquist (eds.1 RNA Genetics Book 2: RNA Variability, 10 promoter-containing fragment of nucleic acid which could 
chapter 3, CRC Press, Orlando, Ha.). Both RNAs 1 and 2 be transferred to a desired new location to generate a novel 
and their gene products are required for viral RNA synthesis; subgenomic ~ R N A .  
RNAsl and 2 encode nonstructural  rotei ins l a  and 2a 
respectively, and these proteins determine RNA-dependent 
RNA polymerase activity. RNA3 encodes nonstructural pro- 15 
tein 3a and coat protein, but neither RNA3, pmtein 3~2, nor 
coat protein is required for viral RNA replication (R. French 
and P. Ahlquist (1986) Science 231:1294). RNA3 can be 
modified by the insertion of a foreign gene in place of the 
coat protein gene, or by certain deletions, without the loss of 20 
replication ability (U.S. patent application Ser. No. 709,181, 
filed Mar. 7, 1985; R. French et al. (1986) Science 
23 1 : 1294). RNA3 has been well studied because its gene 
products are not required for RNA replication (French et al. 
1986). There are regions at the 5' and the 3' noncoding ends 25 
of the molecule which have homologs on RNAs 1 and 2, and 
it has been proposed that these sequences may function in 
viral RNA polymerase recognition, initiation of encapsida- 
tion, protection of the molecules from cellular nucleases, or 
a combination of these functions. Deletion studies using 30 
cloned cDNA and in vitro transcripts have shown that 
portions of the 5' and the 3' ends are required for genomic 
RNA replication, and that there is a graded effect of dele- 
tions in the intercistronic region of RNA3 as well (R. French 
and P. Ahlquist (1987) J. Virol. 61:1457). One feature of the 35 
intercistronic region is an oligo(A) tract, ranging from 
16-22 nucleotides in length in natural virus populations (P. 
Ahlquist et al. (1981) J. Mol. Biol. 153:23). The subgenomic 
promoter of BMV is located in the intercistronic region as 
well. Neither the genomic nor the subgenomic promoters of 40 
the BMV are recognized by host RNA polymerases; only 
virally infected cells have RNA-dependent RNA polymerase 
activity capable of responding to these signals. 
W. Miller et al., 1985, Nature 313:68, established that the 
production of RNA4, which serves as the message for coat 45 
protein, occurs by initiation of RNA synthesis within the 
RNA3 (-) strand molecule. (-) strand RNA3 templates 
ending at the BglII site about 21 bases upstream of the 
RNA4 initiation site were able to direct RNA4 production 
(Miller et al. (1985); L. Marsh et al. (1987) in Positive 50 
Strand RNA Kruses, New York, Alan R. Liss, Inc., 
pp.327-336. These studies and a study by R. French et al. 
(1986) Science 231:1294, show that deletions and insertions 
at or downstream of the SalI site, which is about 17 bases 
downstream of the start site, do not interfere with subge- 55 
nomic mRNA production. French et al, 1986, demonstrated 
the expression of suitably inserted foreign genes by the 
subgenomic pathway. Thus, BMV subgenomic promoter 
activity was thought to be localized to a 37 base region 
which in the cDNA clone lies between the BglII and the SalI 60 
sites. Marsh et al. (1987) also presented evidence from in 
vitro experiments that the 5' boundary of the BMV subge- 
nomic promoter activity was not further upstream than the 
BglII site about 21 bases upstream of the RNA4 start site. 
Marsh et al. (1987) also stated, without evidence, that the 65 
poly(A) tract somewhat further upstream of the RNA4 
initiation site improved promoter activity. Both the studies 
SUMMARY OF THE INVENTION 
The present invention teaches the use of the nucleotide 
sequences which function as a subgenomic promoter of a (+) 
strand RNA virus to direct the amplified expression of a 
structural gene in plant tissue, animal tissue or protist cells 
by RNA-dependent RNA polymerase. This is the first 
instance wherein the nucleotide sequences identifying the 
core region and an upstream activating domain of the 
subgenomic promoter of a (+) strand virus have been iden- 
tified. This subgenomic promoter can be utilized in a modi- 
fied virus, or in an appropriately engineered recombinant 
cDNA derivative which may be chromosomallv integrated 
or maintained as an episoke in transformed cell: The 
invention is exemplified by the subgenomic promoter of 
RNA3 of brome mosaic virus (BMV), but the teachings of 
the present invention allow a skilled artisan to select and use 
subgenomic promoter sequences from similar (+) strand 
RNA viruses for use in any desired cell type. The BMV 
subgenomic promoter is composed of two parts: the core 
promoter, identified by the nucleotide sequence from about 
-21 to about +16, as in FIG. 2, which is sufficient to direct 
subgenomic transcription, and an activating domain, iden- 
tified by the nucleotide sequence from about -95 to about 
-22, as in FIG. 2. The activating domain best acts to increase 
the level of subgenomic transcription when said activating 
domain is located upstream of and in the proper orientation 
relative to said core promoter. Subgenomic transcription is 
dependent on RNA-dependent RNA polymerase activity and 
a (-) strand RNA molecule containing the subgenomic 
promoter and the structural gene; for example the BMV 
subgenomic promoter is recognized by RNA-dependent 
RNA polymerase activities encoded by RNA viruses includ- 
ing, but not limited to, brome mosaic virus and cowpea 
chlorotic mottle virus. Further improvements on the existing 
art are that upstream duplication of the activating domain of 
the subgenomic promoter can increase the level of subge- 
nomic transcription over that directed by a single copy 
subgenomic promoter and that multiple copies of the sub- 
genomic promoter can direct the synthesis of more than one 
subgenomic mRNA molecule from one (-) strand RNA 
template. 
A principal object of the invention is to provide a recom- 
binant DNA molecule containing a DNA copy of the sub- 
genomic promoter of a (+) strand RNA virus and a structural 
gene, wherein the expression of said gene is a two step 
process: pol11 of a host cell transcribes a (-) strand RNA 
molecule canying the functional sequence of the subge- 
nomic promoter and the complementary sequence of said 
structural gene, wherein the synthesis of message-sense 
RNA is under the control of said subgenomic promoter. In 
one embodiment, the subgenomic promoter of RNA3 of 
brome mosaic virus directs the expression of a downstream 
structural gene. RNA polymerase II of the genetically modi- 
fied plant tissue synthesizes an RNA molecule which is a (-) 
sense, functional copy of the subgenomic promoter and a (-) 
sense copy of the structural gene. An RNA-dependent RNA 
polymerase, which may be viral RNA replicase of BMV, 
recognizes the subgenomic promoter and synthesizes a (+) 5 
sense, or functional message-sense, RNA molecule which 
can then be translated into protein. The RNA-dependent 
RNA polymerase activity which responds to the BMV 
subgenomic promoter on the (-) strand RNA molecule may 
be from brome mosaic virus or cowpea chlorotic mottle 10 
virus genetic information, or from a recombinant DNA 
molecule encoding, for example, the la and 2a genes of 
BMV, wherein said genes may be translated into protein 
after transcription by RNA polymerase II of the host cell in 
response to either constitutive promoter or under the regu- 1s 
latory control of a plant regulatory element. 
It is a further object of the invention to provide a method 
for the amplified gene expression in transformed cells com- 
posed of the steps of introducing into a desired host cell a 
recombinant DNA molecule containing a subgenomic pro- 20 
moter from a (+) strand RNA virus and a structural gene, 
wherein expression of the gene is under the regulatory 
control of the subgenomic promoter and wherein the expres- 
sion of that gene depends on transcription by host cellular 
RNA polymerase II to yield a (-) strand RNA molecule 25 
canying the active form of the subgenomic promoter and 
subsequent subgenomic transcription of the gene to yield 
active, (+) sense mRNA by RNA-dependent RNA poly- 
merase activity, and then translation of the subgenomic 
transcript to produce the polypeptide encoded by the struc- 30 
turd gene. The host polII transcription can be controlled by 
a constitutive, inducible or derepressible polII promoter. 
In the figures, and throughout the application, the 
sequences which are the subgenomic promoter are presented 
as the (+) strand sequences, which will be understood to be 35 
the complement of the active subgenomic promoter 
sequences. 
BRIEF DESCRIPTION OF THE FIGURES 
40 FIG. 1 presents a schematic map of BMV RNA3. Non- 
coding regions are shown as a single line, the 3a and coat 
genes as open boxes, the oligo(A) as a small filled box, and 
a bent arrow marks the position of the start of sequences 
encoding subgenomic RNA4. In keeping with common 45 
practice, the sequence of the packaged (+) strand is shown, 
but it should be noted that the complementary sequence 
serves as the template for subgenomic RNA synthesis. 
Numbering in this figure, and in FIGS. 3, 4, 5 and 6, 
subsequent figures, corresponds to that in the published 50 
sequence for RNA3 (P. Ahlquist et al. (1981) J. Mol. Biol. 
153:23). Restriction endonuclease sites are recognized on 
the cDNA molecules carrying the RNA3 sequences. 
FIG. 2 displays the nucleotide sequence of the AvaI-SalI 
fragment of the RNA corresponding to the cDNA clone of 55 
brome mosaic virus RNA3, which fragment comprises the 
sequence of the BMV subgenomic promoter and the initia- 
tion site for subgenomic transcription in the (-) strand RNA 
molecule. The restriction sites shown are for the correspond- 
ing cDNA. Within the sequences shown the AvaI, BglII, and 60 
SalI sites bounding the core promoter are overlined and the 
coat protein initiation codon and the oligo(A) tract are 
underlined. A bent arrow marks the start of the subgenomic 
transcript (RNA4), and the sequence of the 5' end of the 
capped RNA4 molecule is given. 65 
FIG. 3. Schematic diagram of the regions surrounding the 
coat gene cDNA in plasmids pB3TP8 (wild-type), pB3SG5, 
,788 
6 
and pB3SG6. The AvaI-Sac1 fragment duplicated in 
pB3SG5 is bracketed over the wild-type sequence and 
shaded in its new locations in pB3SG5 and pB3SG6. Ini- 
tiation sites for subgenomic RNAs 4 and 4' are shown by 
bent arrows. For pB3SG5 and pB3SG6, the RNA4':RNA3 
ratios were 2.4 and 3.3 respectively. For the wild-type 
plasmid and pB3SG5 the RNA4 :RNA3 ratios were 1.2 and 
0.4, respectively. 
FIG. 4. Effects of 5' deletions on subgenomic promoter 
activity. The sequence surrounding the 3' proximal RNA 
initiation site in derivative pB3SG5, and map of deletions in 
derivatives pB3SG21, 22, and 15. pB3SG11 is the plasmid 
which represents the undeleted sequences. Values given for 
the molar ratios of RNA4':RNA3are the averages of two or 
more independent experiments. 
FIG. 5. Effects of upstream duplications on subgenomic 
promoter activity. Map of the intercistronic region of wild- 
type RNA3 (wt) and sequences duplicated in RNA3 deriva- 
tives pB3IC2, 5, and 6. In each of these derivatives the 
indicated segment of intercistronic sequence is inserted as a 
duplication immediately 5' to position 1015 in the RNA3 
sequence. Values given for the molar ratios of RNA4':RNA3 
are the averages of three independent experiments. For 
comparison, RNA4':RNA3 ratios obtained with no duplica- 
tions of upstream information are generally about 2.4 for 
similar constructions. 
FIG. 6.  Production of multiple subgenomic transcripts 
from individual RNA3 derivatives. Schematic maps of 
RNA3 derivatives pB3SG5, 7, 9, 10, 13, and 14. On each 
line open- headed arrows indicate the sites of insertion of 
additional copies of the AvaI-Sac1 fragment spanning the 
RNA4 initiation site. Above each arrow is given the molar 
ratio of that subgenomic RNA to the genomic RNA3 deriva- 
tive, averaged from two or more independent experiments. 
Each .value is also represented as a histogram bar for visual 
comparison. Arrows with filled heads represent the unaltered 
RNA4 promoter in its wild-type context. The average ratio 
of subgenomic RNA4 to genomic RNA3 production in 
wild-type infection under these conditions is 1.2. 
FIG. 7(A). Alignment of the AvaI-SalI sequence of BMV 
RNA3 to emphasize the presence of imperfect direct repeats. 
This analysis was computer-assisted. The BglII-SalI core 
promoter sequence is shown within the indicated solid box. 
The coat initiation codon, overlapping the SalI site, is also 
marked. 
FIG. 7(B). Sequence alignment showing the similarity 
among BMV, the animal alphaviruses, cowpea chlorotic 
mottle virus (CCMV), and alfalfa mosaic virus (ALMV) 
genomic RNAs near the start of sequences encoding sub- 
genomic rnRNAs for capsid proteins. There is a large gap in 
each plant virus sequence introduced solely to achieve 
alignment with the alphavirus consensus sequence. The bent 
arrow shows the start of subgenomic RNA sequences and 
the initiation codons of the BMV and CCMV coat protein 
genes are underlined. These alignments were generated by 
computer using published sequences; in no virus other than 
BMV has the actual subgenomic promoter been empirically 
determined. The alphavirus consensus was derived from the 
sequences of Sindbis, Middelburg, Sernliki Forest, and Ross 
River viruses (J.-H. Ou et al. (1982) Proc. Natl. Acad. Sci. 
USA 79:5235). The ALMV RNA3 sequence is from R. 
Barker et al. (1983) Nucleic Acids Res. 11:2881, and the 
CCMV RNA3 sequence was determined by P. Ahlquist et al. 
(1981) Cell 23:183. 
FIG. 8 presents schematic representations of normal RNA 
virus replication an the two-stage expression system which 
utilizes the subgenomic promoter for amplified transcrip- 
tion. 
FIG. 8A gives the schematic of successive (-) and (+) 
strand synthesis amplifying viral RNAin normal infection of 
host cells. 5 
FIG. 8B gives the schematic for the similar amplification 
of a chrom&omal transcript by cytoplasmic synthesis of 
multiple complementary copies from a viral subgenomic 
promoter. The nontranslatable primary transcript, which 
itself is a (-) strand with respect to the coding sequence of lo 
the plant-expressible gene, is synthesized by cellular RNA 
polymerase II in response to a polII promoter. RNA-depen- 
dent RNA polymerase activity, such as that induced by the 
l a  and 2a genes of BMV, is necessary to achieve subge- 
nomic transcription of a (+) sense mRNA directed by the l5 
subgenomic promoter sequences present in active form on 
the (-) strand primary transcript RNA molecule. The plant 
tissue can be genetically modified to contain the gene(s) 
encoding RNA-dependent RNA polymerase activity under 
the regulatory control of RNA polymerase II, or that activity 20 
can be expressed during viral infection. Because the polarity 
of the primary transcript is opposite to its product subge- 
nomic RNA, translation of appropriately oriented genes only 
occurs from the secondary subgenomic transcript. Thus, this 
scheme provides control of induction as well as amplifying 25 
expression. 
DETAILED DESCIUPTION OF THE 
INVENTION 30 
The following definitions are provided, in order to remove 
ambiguities to the intent of scope of their usage in the 
specification and claims. 
An RNA virus, as used herein, means a virus whose 35 
genome is RNA in single-stranded form, the single strand 
being a (+), or messenger-sense strand. Replication of the 
viral (+) strand in a cell occurs by a process of direct RNA 
replication and is therefore distinguishable from the mecha- 
nism of retroviral replication which is characterized by an 40 
intermediate step of reverse transcription in the host cell. 
The term subgenomic promoter refers to those sequences 
within an RNA molecule and at the 5' end of a structural 
gene, which direct messenger RNA synthesis using said 
RNA molecule as the template. A subgenomic promoter is 45 
necessary to drive expression of genes using RNA as tem- 
plate; the subgenomic promoter is recognized by an RNA- 
dependent RNA polymerase, which may be a viral RNA 
replicase. The promoter itself may be a composite of seg- 
ments derived from more than one source, naturally occur- 50 
ring or synthetic. It should be noted that a subgenomic 
promoter is located in relation to the particular gene whose 
transcription it initiates, and it is functionally recognized by 
an RNA-dependent RNA polymerase (or viral RNA repli- 
case) when it is contained within an RNA molecule of the 55 
proper (-) polarity. The (-) sense RNA molecule containing 
the functional copy of the subgenomic promoter, which 
comprises the functional units of core promoter and activat- 
ing domain, can be synthesized by RNA-dependent RNA 
polynerase using a (+) sense RNA molecule as template, or 60 
it may have been synthesized by (cellular) RNA polymerase 
I1 as a transcript initiated by a polII promoter. A specific 
embodiment of the present invention is the subgenomic 
promoter of RNA3 of brome mosaic virus (BMV). The 
identifying sequence of the subgenomic promoter of BMV 65 
is given in FIG. 2. For consistency herein, the position of the 
brome mosaic virus subgenomic promoter has been given 
relative to the start site of the subgenomic mRNA, which is 
designated +I. The BMV subgenomic promoter comprises 
the nucleotide sequence extending from about -95 to about 
+17, as in FIG. 2; the sequence comprised within the region 
from about -74 to about +16 also constitutes a functional 
subgenomic promoter. 
The core promoter of a subgenomic promoter includes the 
minimum sequence required for function. In the case of 
BMV the core promoter comprises the nucleotide sequence 
from about -21 to about +17, as in FIG. 2. When correctly 
positioned as is understood in the art, the core promoter is 
sufficient to direct the initiation of message synthesis by an 
RNA-dependent RNA polymerase so that (+)strand RNA 
molecules are synthesized. 
The activating domain of a subgenomic promoter includes 
sequences which increase the activity of the core promoter 
allowing for increased synthesis of subgenomic transcripts. 
In the case of BMV, the activating domain which can 
increase synthesis of mRNA directed by a subgenomic 
promoter, or a subgenomic core promoter, relative to the 
levels obtained when only the core promoter sequences are 
present, comprises the nucleotide sequence between about 
-95 and about -22, as in FIG. 2. Somewhat less activation 
is obtained with the sequence from about -74 to about -22. 
RNA dependent RNA polymerase herein refers to an RNA 
synthetic enzyme which faithfully initiates (+) strand RNA 
synthesis in response to an RNA sequence which is a 
subgenomic promoter, and which is contained within a RNA 
molecule which is (-) sense relative to the coding region of 
the associated structural gene. For example, the l a  and 2a 
genes of BMV determine RNA-dependent RNA polymerase 
activity in cells within which those genes are expressed, and 
that RNA-dependent RNA polymerase activity recognizes 
subgenomic promoters including, but not limited to, those of 
brome mosaic virus and cowpea chlorotic mottle virus. 
The term subgenomic transcription refers herein to the 
synthesis of RNA by an RNA-dependent RNA polymerase 
wherein said RNA-dependent RNA polymerase uses a (-) 
strand of RNA as template, and wherein said RNA-depen- 
dent RNA polymerase initiates the synthesis of mRNA in 
response to the nucleotide sequence information contained 
within the subgenomic promoter. 
The term (+) strand RNA refers to RNA which is mes- 
senger-sense with respect to coding regions. 
The term (-) sense RNA refers to sequences which are the 
complement of (+) sense molecules. For example, the (-) 
sense RNA molecule corresponding to a structural gene is 
complementary in sequence to the message, and the (-) 
sense RNA molecule cannot itself act as a message for the 
translation of the corresponding protein. 
The term polII promoter herein refers to DNA sequences 
at the 5' end of genes which direct the initiation of tran- 
scription by the DNA-dependent enzyme RNA polymerase 
I1 of plant or animal cells. Promoter sequences are necessary, 
but not always sufficient, to drive the expression of down- 
stream genes. The promoter itself may be a composite of 
segments derived from more than one source, naturally 
occumng or synthetic. Eukaryotic poll1 promoters are com- 
monly identified by the presence of DNA sequences 
homologous to the canonical form 5'-TATAA-3' 
("TATA" box) about 10-30 bp 5' to the location of the 5'-end 
of the mRNA (cap site, +I). About 30 bp 5' to the TATA box 
another promoter component sequence is often, but not 
always, found which is identified by the presence of DNA 
sequences homologous to the canonical form 5'-CCAAT -3'. 
For the purposes of the present description, a pol11 promoter 
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is defined to include DNA sequence extending up to about A recombinant DNA molecule is one which has been 
100 bp 5'(-100) to the cap site. Any additional sequences either naturally or artificially produced from parts derived 
which may be located 5' to -100, and which may contain from heterologous sources, which parts may be naturally 
functionality including, but not limited to, that of Wanscrip- occurring or chemically synthesized molecules, and wherein 
tion activating element or sequences exerting regulation in those parts have ken joined by ligation or other means 
response to environmental stimuli, are considered promoter- lcnown to the art. 
associated elements, but for the purposes of this application, 
are considered part of the polII promoter, even though said Plant tissue includes differentiated and undifferentiated 
sequences may be recognized by cellular proteins other than tissues of plants including, but not limited to, roots, shoots, 
DNA-dependent RNA polymerae u. (A polymerae is leaves, pollen, seeds, tWTIor lissue such as crown g&sUs, and 
to  recognize^ a particular DNA sequence if hat sequence various forms of aggregations of plant cells in culture such 
is necessary to or has regulatory effect on initiation of as embryos and calli. The plam tissue may be in planh, or 
transcription by the polymerase.) It should be noted that a in Organ, Or 
pol11 promoter is generally located 5' to the particular gene The term chemically synthesized, as related to a sequence 
whose transcription it initiates. That transcript may be a (+) 15 of DNA, means that the component nucleotides were 
sense RNA molecule which can serve as a message or it may assembled in vitro using nonenz~matic n~eans. Manual 
be a (-) strand RNA molecule which can serve as a template synthesis of DNA may be accomplished using well estab- 
for subsequent RNA synthesis. lished procedures (i.e. M. Caruthers (1983) in Methodology 
Expression refers to the transcription and translation of a DNA and RNA Sequencing* Weissman (ed.)3 
structural gene so that a is made. Gene expression 20 hblishers (New York) Chapter 1) or automated synthesis 
can be assessed by direct detection of the protein by Can be ~edormed using one of a number of commercially 
protein gel electrophoresis or immunological methods, for machines. 
example. Oftentimes, expression is assessed by detection of Homology as used herein, refers to identity of nucleotide 
the ~ R N A  products of transcription. This method is par- sequences. The extent of homology between DNA 
titularly appropriate for the assessment of transcriptional 25 Sequences can be empirically determined in DNA hybrid- 
control factors, such as promoter elements, since the effects ization experiments, such as those described in B. H a m s  
of nontranscriptional processes, such as protein degradation, and S. Higgins (1985) Nucleic Acid Hybridisation, IRL 
are excluded. Press, Oxford, UK. 
A structural gene refers to the combination of nucleotide Because there is some flexibility with respect to the 
sequences encoding a protein and (some of) the regulatory 30 Sequences carried on BMV it was possible to exam- 
sequences which allow expression of that structural gene in ine how certain RNA sequences in the intercistronic region 
a plant cell or tissue. The term structural gene refers to that contributed to subgenomic promoter activity. It was known 
portion of a gene composed of a DNA segment coding for that initiation of subgenomic RNA synthesis does not 
a protein, polypeptide or portion thereof, possibly including require more than 16 bases downstream of the start site (i.e. 
a ribosome binding site and/or translational start codon. The 35 3' to the Start of RNA4 sequences in the virion-sense RNA) 
term can also refer to copies of a structural gene naturally (W- Miller et (1985) Nature 313:68; R. French et al. 
found within the cell, but artificially introduced. In this case (1986) Science 231:1294; L. Marsh et d. (1987) in Positive 
a structural gene naturally found in a cell may be reintro- Strand RNA Kruses, Alan R. Liss, Inc., New York, 
duced into a cell as part of a chimeric gene having non- pp.327-336). Infectious in vitro transcripts synthesized from 
natural regulatory control sequences, for example under the 40 engineered RNA3 cDNA clones were used to determine the 
control of the BMV subgenomic promoter. The structural effects of alterations in the primary structure of RNA3. A 
gene may encode a protein not normally found in the plant restriction map of the cDNA clone of BMV RNA3 and the 
cell in which the gene is introduced, in which case it is nucleotide sequence of the Avd-SalI region surrounding the 
termed a foreign structural gene. A foreign structural gene subgenomic transcript start sites are given in FIGS. 1 and 2. 
may be derived in whole or part from a bacterial genome or 45 A notable feature of the sequence upstream from the sub- 
episome, eukaryotic nuclear or plastid DNA, cDNA, viral genomic message start site is an oligo(A) tract which is 
DNA, or chemically synthesized DNA. It is further contern- conserved at equivalent genomic positions h other members 
plated that a structural gene may contain one or more of the br~movirus group (P. Ahlquist et al. (1981) Cell 
modifications in either the coding segments or in the 231183; unpublished observations). TO determine whether 
untranslated regions which could affect the biological activ- 50 the oligo(A) tract affects subgenomic Promoter activity, 
ity or the chemical structure of the expression product, the mutant plasmid P B ~ I C ~ ,  which lacks all but one A residue, 
rate of expression, or the manner of expression control. Such was constructed. That in vie0 RNA3 transcript possessed 
modifications include, but are not limited to, insertions, less than 10% of the parental subgenomic Promoter activity 
deletions and substitutions of one or more nucleotides. The in viva. The length of the oligo(A) tract ranges in length 
structural gene may constitute an uninterrupted coding 55 from 16-22 in natural RNA3 populations (P. Ahlquist et al. 
sequence or it may include one or more introns, bounded by (1981) J. Mol. Biol. 153:23). In P B ~ T P ~  there are 18 A 
host cell-functional splice junctions. The structural gene residues (M. Jan& et al. (1987) Virology 158:259). Subge- 
may be a composite of segments derived from a plurality of nomic Promoters containing oligo(A) tracts differing in 
sources, naturally occurring or synthetic. That structural length from the 18 as in FIG. 2, will be considered func- 
gene may also produce a fusion protein. It is contemplated 60 tionally equivalent to the BMV subgenomic Promoter of 
that the introduction into host cells of recombinant DNA FIG. 2, provided that similar amounts of SeqUenCe informa- 
containing the structural gene in combination with a subge- tion flanking the oligo(A) are maintained. 
nomic promoter or with a polII promoter will include In the test system, parental RNA3 transcripts produced 
constructions in which the structural gene is not derived progeny (+) strand RNAs at a ratio of RNA4:RNA3 of 1.2. 
from the same kind of cell as the host, and constructions 65 To separate the effects of sequence changes in the intercis- 
wherein additional copies of naturally occurring genes are tronic region on subgenomic message production from 
expressed under BMV subgenomic promoter control. effects OE genomic RNA3 amplification, a second subge- 
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nomic initiation site was established by inserting the AvaI- transcription led to a stimulation in subgenomic RNA syn- 
SacI fragment of cDNA spanning the start site at the XbaI thesis. The structures and the RNA4:RNA3 ratios for wild- 
site of the RNA3 cDNA to create pB3SG5 (FIG. 3). pB3SG5 type and the mutant plasmids is given in FIG. 5. Significant 
transcripts were replicated, and directed the synthesis of two stimulation of subgenomic RNA synthesis was achieved by 
subgenomic RNAs as intended. The subgenomic mRNA 5 duplicating the sequence contained within the activating 
produced from the engineered copy of the subgenomic domain, an AvaI-BglII fragment from about -95 to about 
promoter (RNA4') was more abundant than both the -21 of the cDNA of RNA3 upstream of RNA start site. 
genomic RNA3 and the subgenomic mRNA originating While the oligo(A) tract contributed to that stimulation, it 
from the wild-type subgenomic promoter. A ratio of was not required for stimulation to occur. 
RNM':RNA3 of 2.41 was obtained from pB3SG5. lo To determine whether sites other than the XbaI site could 
P B ~ S G ~ ,  which contained only one COPY of the subgenomic support subgenomic RNA synthesis when the AvaI-Sac1 
Promoter at the same distal location as that of P B ~ S G ~ ,  fragment was present, the AvaI-Sac1 fragment of RNA3 was 
produced subgenomic and genomic W A S  at a ratio of 2.5: 1. duplicated at a ClaI site 5' to the normal RNA4 start site in 
The sizes of subgenomic RNA species obtained with pB3SG7. Both subgenomic promoters were functional, and 
pB3SG5 and pB3SG6 were consistent with initiation from 15 as in other cases where there were two copies of the 
the expected sites in the duplicated promoter sequences. subgenomic Promoter, the smaller of the subgenomic RNAs 
Primer extension experiments confirmed that the initiation was more abundant. Mutant RNA3 cDNA clones were also 
site for subgenomic WA synthesis was unchanged even constructed to test whether more than two subgenomic 
when the subgenomic promoter was moved to a new loca- promoters Were functional in a single RNA3 derivative. 
tion or was duplicated within the RNA3 cDNA clone. Like 20 P B ~ S G ~  and pB3SG10 each contained two ~vaI-SacI  sub- 
wild-type RNA4 @. Dasgupta et al. (1976) J. Virol. 18:260), genomic promoter fragments while pB3SG13 and pB3SG14 
the subgenomic RNA produced from the novel subgenomic each contained three. It was found that the subgenomic 
RNA initiation site was capped. promoter was active at each location tested, and a distinct 
Further functionality of RNA sequences in the region gradient favoring greater accumulation of subgenomic 
upstream of the subgenomic RNA start site was examined by 25 W A S  from 3' proximal sites was observed in these experi- 
determining the effects of a series of internal insertion and ments (FIG. 6).  observed activation of subgenomic 
deletion mutations on subgenomic mRNA synthesis in plant transcription is a consequence of upstream duplications of 
tissue. A second functional subgenomic promoter was estab- subgenomic promoter 
lished distal to the intercistronic region; therefore, it was The ability of the subgenomic promoter fragment to 
possible to use deletion analysis to investigate the 5' limits 30 function in the reverse orientation relative to the surrounding 
of sequences contributing to subgenomic RNA synthesis cDNA was tested in P B ~ S G ~ R  and P B ~ S G ~ R .  No putative 
without significant affects on full-length RNA3 accumula- subgenomic RNA species were observed. In both cases the 
tion. In protoplast infections these deletions induced an inversion caused severe inhibition of RNA3 accumulation. 
obvious progressive decline in subgenomic W A  production For SG6R, with its 26 b inverted repeat, only a small amount 
as the deletions extended further 5'. The decreased accumu- 35 of RNA3 could be detected on overexPosures of the auto- 
lation must reflect reduced synthesis because the sequence radiographs, but SG5R with its 330 bp inverted repeat never 
of the subgenomic WA, and therefore its stability, was gave detectable RNA3 production. NO internally initiated 
unchanged in the various constructions. The results are ''~seudo-subgenomic" RNA species of negative polarity 
summarized in FIG. 4. pB3SG11 carried the Av&SalI Were detected from either C O ~ S ~ I U C ~ ~ O ~ .  
fragment containing about 95 bases upstream of through 40 Computer-assisted sequence inspection revealed that the 
about 16 bases downstream of the start of subgenomic 120 base AvaI-SalI region of the RNA3 cDNA, which 
transcription. The RNA4':RNA3 ratio of 2.5 was similar to contains the core promoter and the activating domain of the 
that of pB3SG5, which carried the sequence information subgenomic promoter, includes several imperfect direct 
through the SacI site well into the coat protein gene. repeats (FIG. 7). The 30 bases overlapping and immediately 
pB3SG21, containing subgenomic promoter sequences from 45 5' to the oligo(A) tract have 67% identity with the BglII-SalI 
the BstXI site about -74 through the SalI site downstream of core promoter region, with the 3' boundary of this duplica- 
the start site, produced an RNAC:RNA3 ratio similar to the tion corresponding precisely to the start of the coat protein 
RNA4:RNA3 ratio of the wild-type plasmid, but lower than coding region. Immediately 5' to this duplication is a clearly 
that of pB3SGll. Further deletions of the upstream region related segment which also includes a single-mismatch 
gave further decreases in the RNA4':RNA3 ratios. pB3SG15 50 repeat of the consensus element 5'-AUCUAUGUU-3'. 
was the plasmid with the shortest subgenomic promoter Thus, nearly all of the AvaI-SalI promoter region consists of 
fragment (BglII-SalI); the RNAC:RNA3 ratio was 0.3:1, repeats or partial repeats of sequences related to the core 
showing that the efficiency of the truncated subgenomic promoter, punctuated in one area by the oligo(A). Although 
promoter was limited. Thus, the 5' end of the core promoter similar in sequence, the two copies of the core promoter 
is no further 5' than -21, and all information necessary for 55 motif flanking the oligo(A) were clearly not equivalent. 
efficient initiation is 3' to about -95, with results similar to While the 3' copy contains a weak but functional promoter, 
that of the wild-type plasmid ratio when only about 74 bases no subgenomic RNA initiation was detected at the corre- 
of upstream information are present. Therefore, the BglII- sponding site in the 5' copy of this motif. 
SalI fragment, from about -21 to about +16 as in FIG. 2, As shown in FIG. 7, the oligo(A)/core promoter region of 
comprises the BMV subgenomic core promoter. The A d -  60 BMV RNA3 contains similarities to the analogous regions 
SalI fragment, from about -95 to about +16, as in FIG. 2, near the subgenomic mRNA start sites in some other plant 
and the BstXI-SalI fragment, from about -74 to about +16, WA viruses, including cowpea cNorotic mottle virus 
as in FIG. 2, both contain activating domain and core (CCMV) and alfalfa mosaic virus (AMV). BMV is the only 
promoter activities of the subgenomic promoter. (+) strand RNA virus for which the subgenomic promoter 
Duplication of subgenomic promoter activating domain 65 sequences have been determined experimentally. FIG. 7 also 
sequences from the RNA3 intercistronic region at a site displays the significant homology of the sequence from the 
some 220 bases upstream of the start site for subgenomic BMV subgenomic promoter region to the consensus 
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sequence from just upstream of the start of alphavirus nomic promoter is in a site other than its normal site within 
subgenomic RNA (taken from J.-H. Ou et al. (1982) Proc. the RNA3 derivative, and enhancement of subgenomic 
Natl. Acad. Sci. USA 795235-5239); the functionality of transcription may be achieved by duplication of the activat- 
the alphavirus consensus sequence in directing subgenomic ing domain portion of the subgenomic promoter. 
RNA synthesis has not been test*. The sequence simi1a1-i- 5 From the data presented herein, location, isolation and use 
ties shown in FIG. 7 overlap the BMV consensus element of subgenomic promoters from other sources can be readily 
AUCUAUGUU which, with single mismatches, is repeated carried out by those of ordinary skill in the art without undue 
three times in the BMV AvaI-SalI fragment (FIG. 7A). experimentation. The comparative sequence data of FIG. 7 
Deletions of the upstream repeated sequences (FIG. 4) show remarkable homology over a wide range of RNA 
resulted in decreased subgenomic promoter activity. Fur- lo sources known to possess subgenomic promoters. From 
thermore, RNA4 synthesis was shown to proceed correctly such data, together with known or readily obtainable data on 
from a CCMV RNA3 when BMV RNAsl and 2 were subgenomic transcription start sites, subgenomic promoters 
provided in a co-infection and similarly, co-infections of equivalent to that of BMV RNA3 can be isolated and used 
BMV RNA3 with CCMV 1 and 2 yield accurately as described and exemplified herein. The recognized homol- 
synthesized RNA4. Previously published studies of BMV 15 ogy and mode of action of RNA-de~endent RNA ~ 0 1 ~ -  
subgenomic transcription were based on in vitro experi- merases allows for the mixed combination of subgenomic 
merits carried out uskg extracts made from BMV-infected promoter and RNA-dependent RNA polymerase from het- 
barley cells (L. Marsh et al. (1987) in Positive Strand RNA erologous sources, or demonstrated herein for BMV and 
E w e s ,  Alan R. Liss, Inc., New York; W. Miller et al. (1985) CCMV. However, it will be understood that differences in 
Nature 313:68). The work of the present invention was zo rate of transcription and Promoter specificity can lead to 
performed using in viva experiments to study subgenomic quantitative differences in expression, depending on the 
RNA synthesis. The current results demonstrate that the particular combination of Promoter and polymerase 
BglII-SalI region of cDNA for BMV RNA3 has some employed. 
subgenomic promoter activity in vivo, however, sequence It is an object of this invention to provide a method for the 
information upstream of the BglII site (the AvaI-BglII region 25 amplified expression in plant tissue of a structural gene 
from about -95 to about -21 relative to the start site) under the regulatory control of an RNA virus subgenomic 
constitutes an activating domain which is required for effi- promoter, which in one embodiment can be the subgenomic 
cient synthesis of subgenomic RNA by RNA-dependent promoter of brome mosaic virus. The method is composed 
RNA polymerase. In addition, the work of the present of the following steps: introducing into plant tissue a recom- 
invention demonstrated that a fragment of DNA (e.g., the 30 binant DNA molecule containing the subgenomic promoter 
AvaI-SalI fragment) containing the subgenomic promoter and a structural gene such that the expression of said gene 
could be moved to a novel location within an RNA sequence is under the regulatory control of the subgenomic promoter 
with subgenomic promoter activity retained. Furthermore, and the entire combination is of a conventional polII pro- 
several subgenomic promoters have now been shown to be moter, either constitutive, inducible or derepressible, syn- 
functional within a single RNA3 derivative even if located 35 thesis by cellular RNA polymerase I1 of a primary, (-) strand 
at separate sites leading to a plurality of subgenomic RNA transcript containing the subgenomic promoter in its active 
transcripts. Still further, it was determined that a fragment form and the complement of the coding sequence of the 
carrying the activating domain of a subgenomic promoter structural gene, and expression of RNA-dependent RNA 
could be duplicated upstream of the subgenomic promoter polymerase activity (for example, by the infection of the 
with the unexpected result that subgenomic transcription 40 modified plant tissue with brome mosaic virus, or by induc- 
was enhanced. ing chromosomally integrated copies of the BMV la and 2a 
A principal feature of the present invention is the brome genes under the control of pol11 promoters), followed by 
mosaic virus subgenomic promoter, which is identified by subgenomic transcription to yield a secondary, (+) sense 
the nucleotide sequence as in HG. 2, nucleotides -95 to +16 mRNA encoding the structural gene which is then translated 
relative to the start site for subgenomic transcription. This 45 to yield its protein product. This scheme has the advantage 
nucleotide sequence was sufficient to direct subgenomic that in the absence of RNA-dependent RNA polymerase 
RNA synthesis from a novel site on the viral genome at activity the structural gene is completely silent because there 
wild-type or greater levels. Sequences no more than about is "0 (+) sense RNAs~nthesized, and therefore, there can be 
20 bases upstream of the start site sufficed to direct specific "0 translation to yield the protein product of that gene. 
initiation at a low level; therefore the region between -21 50 Generally genes under the regulatory control of regulated 
and +16 is termed the subgenomic core promoter. Sequences poln Promoters and associated sequence elements exhibit 
at least as far as 74, but no more than 95 bases upstream are some degree of expression even in the absence of inducing 
required for full promoter activity. The oligo(A) tract conditions. Use of a subgenomic promoter is therefore 
the region between -21 and -74 is an important functional ~Seful  to prevent expression of a gene which would be lethal 
element in full subgenomic promoter activity, and may 55 for the cell which expresses it. When such a gene is tightly 
function as a recognition sequence element or may provide controlled SO that it is only expressed after infection with 
spacing or flexibility between other elements of the pro- virus, its expression kills the infected cell before virus 
meter. The function of the sequence elements with homol- replication and dissemination occur. This process constitutes 
ogy to the consensus element AUCUAUGUU is not known, an effective I'rIeanS for contr~lling virus infection in plant 
but analogy to DNA-dependent transcription suggests that 60 tissue, and therefore a way to Prevent crop damage and 
these sequences might be recognized by trans-acting fat- economic loss. The advantages of this scheme would be lost 
tor(s) to increase the level of subgenomic transcription. if the control of lethal gene expression were not virtually 
Further increases in the level of subgenomic transcription absolute, and are therefore not feasible with prior art pol11 
were obtained by duplicating the sequence information of Promoters. 
the AvaI-BglII fragment upstream from the start site, as in 65 Another consequence of the use of a subgenomic pro- 
FIGS. 2 and 5. The subgenomic promoter can be used to moter is the rapid amplification of expression once an active 
direct the expression of a structural gene when the subge- RNA-dependent RNA polymerase is present. The promoter 
is therefore useful to express any gene when a sudden burst 
of expression is desired. For example, rapid but transitory 
expression of high-level herbicide resistance can be obtained 
by providing a herbicide-resistance gene under subgenomic 
promoter control and an RNA-dependent RNA polymerase 
under control of an inducible or derepressible pol11 pro- 
moter. The latter can be chosen to turn on polymerase 
expression in response to a component in the herbicide 
formulation. Other specific resistances can be regulated in a 
similar manner and will be especially useful where the 
resistance is the result of expressing a gene that leads to 
production of a toxic distasteful or otherwise undesirable 
substance. High level, transitory expression of such a gene 
can be achieved using an innocuous inducing agent, so as to 
produce the desired resistance at precisely the desired stage 
in the host organism's life cycle. Later, for example at 
harvest, when the gene is not expressed, the undesirable 
substance is absent from plant tissue intended for consump- 
tion. 
It will be understood by those of ordinary skill in the art 
that the use of subgenomic promoter-structural gene com- 
binations is not confined to plants. Positive strand RNA 
viruses exist for bacteria and animal cells as well as plants, 
and subgenomic promoter homology is seen for both plant 
and animal viruses. Therefore, expression of a structural 
gene under subgenomic promoter control can be accom- 
plished in any transformable cell including, without limita- 
tion, plant cells, animal cells and bacterial cells. 
The production of genetically modified plant tissue con- 
taining and expressing a structural gene under the transcrip- 
tional control of the BMV subgenomic promoter combines 
the specific teachings of the present disclosure with a variety 
of techniques and expedients known in the art. In most 
instances, alternative expedients exist for each stage of the 
process. The choice of expedients depends on variables such 
as the choice of vector system for the introduction and stable 
maintenance of the expression complex, the cell type, 
whether plant, animal or protist, to be modified and, in the 
case of plants, the desired regeneration strategy, and the 
particular structural gene to be used, all of which present 
alternative process steps which those of ordinary skill in the 
art are able to select and use to achieve a desired result. 
Homologs of structural genes or of other sequences may 
be identified by the ability of their nucleic acids to cross- 
hybridize under conditions of appropriate stringency as is 
well understood in the art. It will be understood that there 
may be minor sequence variations within sequences utilized 
or disclosed in the present application. It is well known in 
the art that some DNA sequences within a larger stretch of 
sequence are more important than others i n  determining 
functionality. A skilled artisan can test allowable variations 
in sequence, without undue experimentation, by well known 
mutagenic techniques which include, but are not limited to, 
those discussed by D. Shortle et al. (1981) Ann. Rev. Genet. 
15:265; M. Smith (1985) ibid. 19:423; D. Botstein and D. 
Shortle (1 985) Science 229: 1193; by linker scanning 
mutagenesis (S. McKnight and R. Kingsbury (1982) Science 
217:316) or by saturation mutagenesis (R. Myers et al. 
(1986) Science 232:613). These variations may be deter- 
mined by standard techniques in combination with assay 
methods described herein to enable those skilled in the art to 
manipulate and bring into utility the functional units of pol11 
promoters, structural genes, and subgenomic promoters. 
Using the methods described herein the skilled artisan can, 
without undue experimentation, test altered sequences 
within a subgenomic promoter for retention of function. The 
final steps of the preferred embodiment for obtaining geneti- 
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cally modified plant tissue include inserting the expression 
complex into a T-DNA-containing vector, and transfemng 
the recombinant DNA to plant tissue wherein the modified 
T-DNA becomes stably integrated as a part of the genome. 
Other techniques for transforming plant cells, including 
protoplast transformation, electroporation, micro-injection 
and agroinfection can be employed. 
The following examples are provided for illustrative 
purposes only and are not intended to limit the scope of the 
invention. The examples utilize many techniques well 
known and accessible to those skilled in the arts of molecu- 
lar biology, in the manipulation of recombinant DNA in 
plant tissue, and in the culture and regeneration of trans- 
formed plants. Techniques for similar manipulations of 
recombinant DNA in animal and bacterial cells are well 
known. Enzymes are obtained from commercial sources and 
are used according to the vendors' recommendations or 
other variations known in the art. Reagents, buffers, and 
cultural conditions are also known to the art. References 
containing standard molecular biological procedures include 
T. Maniatis et al. (1982) Molecular Cloning, Cold Spring 
Harbor Laboratory, Cold Spring Harbor, N.Y.; R. Wu (ed.) 
(1979) Meth. Enzymol. 68; R. Wu et al. (eds.) (1983) 
Methods Enzymol. 100 and 101; L. Grossman and K. 
Moldave (eds.) Methods Enzymol. (1980) 65; J. Miller (ed.) 
(1972) Experiments in Molecular Genetics, Cold Spring 
Harbor Laboratory, Cold Spring Harbor, N.Y.; Old and 
Primrose (1981) Principles of Gene Manipulation, Univer- 
sity of California Press, Berkeley, Calif.; R. Schlief and P. 
Wensink (1982) Practical Methods in Molecular Biology, 
Springer-Verlaz Berlin Glover (ed.) (1985) DNA Cloning, 
Vols. I and 11, IRL Press, Oxford, UK, B. Hames and S. 
Higgins (eds.) (1985) Nucleic Acid Hybridization, IRL 
Press, Oxford, UK; P. Setlow and A. Hollaender (1979) 
Genetic Engineering: Principles and Metho&, Vols. 1-4, 
Plenum Press, New York. Abbreviations and nomenclature, 
where employed, are deemed standard in the field and 
commonly used in professional journals such as those cited 
herein. 
EXAMPLE 1 
This example describes the recombinant DNA molecules 
and the cloning strategies used to characterize the BMV 
subgenomic promoter sequences. 
1.1 Wild-Type cDNA Clones of Brome Mosaic Virus in 
Transcription Vector Plasmids 
Plasmids pBlTP3, pB2TP5, and pB3TP8 contain cDNA 
copies of BMV RNAs 1, 2, and 3, respectively, from which 
properly initiated, capped and infectious transcripts of the 
complete BMV genome can be produced with T7 RNA 
polymerase (M. Janda et al. (1987) Virol. 158:259). Other 
plasmids used in the construction of RNA3 derivatives were 
pB3TP7 (M. Janda et al. (1987) and pB3PM1 (P. Ahlquist 
and M. Janda (1984) Mol. Cell. Biol. 4:2876-2882). Those 
plasmids contain the same BMV cDNA region as pB3TP8, 
but are linked to a T7 promoter with a single intervening G 
residue, and linked directly to an E. coli promoter, respec- 
tively. All the above plasmids except pB3M1 are pUC119 
derivatives, and so contain the ssDNA replication origin of 
bacteriophage M13, allowing recovery of ssDNA forms 
after superinfection with suitable helper phage, such as 
M13K07 (provided by J. Vieira). 
1.2 Plasmid Constructions with Mutant BMV Construc- 
tions 
Standard methods were used with minor modifications (T. 
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Maniatis et al. (1982) Molecular Cloning, Cold Spring EXAMPLE 2 
Harbor Laboratory, Cold Spring Harbor, N.Y.). To join 
noncomplementary ends of fragments produced by different In Vitro Transcription, Protoplast Inoculations and 
restriction endonucleases, 3' protruding ends were trimmed RNA Analysis 
to bluntness with T4 DNA polymerase, and 3' recessed ends 5 
, This exmple describes the techniques used to examine 
were extended to bluntness with either the large fragment of the functionality of BMV wild-type or altered subgenomic 
E. coli DNA polymerase I or T4 DNA polymerase. promoter sequences. 
P B ~ I C ~ :  E. coli RZ1032 (dut, ung) (T. Kunkel (1985) Barley protoplasts were isolated as described (L. Loesch- 
Nat. Sci. USA 82:488) was transformed with 10 Fries and T. Hall (1980) J. Gen. Virol. 47:323). In vitro 
pB3TP8 and dUTP-containing was after transcription in the presence of m7GpppG or GpppG, pro- 
superinfection with M13K07. This DNA was used as a toplast inoculation and incubation, viral RNA extraction and template for oligonucleotide-directed mutagenesis (Kunkel, 
1985) to delete 17 of the 18 residues of the pB3TP8 analysis and densitometry of the resulting autoradiographs 
intercistronic oligo(A) tract, and the product clones were were ~ ~ e d  out as d€XTibed Prench and Ahlquistl lgg7). 
screened by dideoxynucleotide sequencing (M. Biggen et al. 15 Each plasmid was tested in at least three 
(1983) Proc. Nat. Acad. Sci. USA 80:3963). The mutagenic Probes for the (+) strand RNA 
oligonucleotide used was ~(GACATA- were a 32P-labelled SP6 transcript from subclone pB3HE1, 
GATCTAATAATAAC). A single A residue from the oli- which contains the 200 base Hindm-Ec0R.I fragment of 3' 
go(A) was retained to preserve the BglII site at the 5' terminal RNA3 cDNA sequences from pB3TP8, or in cer- 
boundary of the core promoter. pB3IC4 is the plasmid which 20 tain experiments (FIG. 6 of MS) a similar in vitro transcript 
lacks the oligo(A) tract in the subgenomic promoter region. complementary to the BglII-Sac11 region of RNA3. Dena- 
pB3SG5, 5R, 9, 10, 11, 13, 14, 15, 21, 22: Copies of the turing gel electro~horesis for negative strand RNA analysis 
AvaI- Sac1 fragment of pB3TW were inserted as duplica- was carried out on f o d d e h y d e  genes (Maniatis et al., 
tions in the indicated sites of the RNA3 cDNA region of 1982). Probes for the negative strand RNAs were in vitro 
pB3TP7: pB3SG5: XbaI; pB3SG7: ClaI; pB3SG9: ClaI, 25 transcripts from subclones covering the AvaI-Sac1 region of 
XbaI; pB3SG10: XbaI,StuI; pB3SG13; ClaI, XbaI, StuI; BMV RNA3. 
pB3SG14: NsiI, XbaI, StuI. Restriction analysis was used to primer extension experiments were out after 
select those insertions with the same orientation as the inoculation of 106 protop~asts with transcripts o f ~ ~ l  and 
surrounding rounds of 'Ioning were RNA2 cDNA clones (pB1TP3 and pB2TP5) and transcripts 
required to construct those derivatives with multiple inser- 30 of the appropriate RNA3 cDNA clone. After incubation for 
tions of the subgenomic Promoter fragment. In the cases of 24 h under continuous light, total nucleic acids were isolated 
multiple promoter constructions, the use of the AvaI-Sac1 
fragment rather than the smaller AvaI-SalI fragment allowed and dissolved in 15 pl ddH20. 1.5 pl of this nucleic acid was 
the distinction of the resulting subgenomic RNA species mixed with 1 ng of 5'-32P labelled d(GCGAGTCATCT- 
differentiable in size by gel electrophoresis. TACC) (complementary to bases 2 8 4 2  of BMV RNA4) in 
35 a total volume of 4 pl with 1.5 units of reverse transcriptase 
pB3SG5R contains the AvaI-SaC1 fragment in the reverse (Life Sciences, Inc.) deoxynucleotides at 25 @I each, and 
orientation at the XbaI site of pB3TP7. final concentrations of 25 mM Tris-C1 pH 8.3,5 mM MgCl,, pB3SG11 contains the AvaI-SalI fragment as a duplica- 25 mM KCI, and mM DTT. After incubation for 30 
tion at the XbaI site P ~ ~ ~ ~ .  ~~~~~~~9 at 37 C., the products were denatured at 95 C. for 3 min. in 
P ~ ~ ~ ~ ~ ~ ,  and P~~  contain the Bgln-Sall, BsX1-Sally and 40 an equal volume of 90% fomamide, 20 mM EDTA, 0.1% 
DdeI-SalI fragments, respectively. 
xylene cyanol, 0.1% bromphenol blue, and 3 pl aliquots 
P B ~ S G ~ ,  6R: P B ~ B B ~  is a pB3TP7 derivative in which a were electrophoresed on a 12% polyacrylamide, 8.3M urea 
deletion from base 1168 to the d ~ ~ n s t r e a m  Sac1 site has gel. Marker lanes were prepared similarly except that each 
been introduced (R. A. French and P. Ahlquist), (1987) J. reaction contained 50 @I of a single deoxynucleotide, and 
Viral. 61:1457). The AvaI-SacI fragment of P B ~ T P ~  was 45 the template was ssDNA prepared from phage particles 
introduced into the Xbd  site of P B ~ B B ~  in the same isolated after superinfection of pB3SG6-transformed E. coli 
orientation as the surrounding cDNA to create P B ~ S G ~ ,  and with helper phage M13K07. Sequence comparisons were 
in the reverse orientation to create pB3SG6R. made with the assistance of software from the University of 
pB3IC2,3,5,6: In separate constructions, a BarnHI linker Wisconsin Genetics Computer Group. 
(CGCGGATCCGCG, New England Biolabs) was inserted 50 
in the AvaI and BglII sites of pB3M1 after filling out the EXAMPLE 3 
recessed ends with the Klenow DNA polymerase. The small 
PstI-BamHI fragment of each of these plasmids was ligated Construction of pB3-SGP and Gene Expression 
with the large PstI-BamHI fragment of pB3BC1 (French and 
Ahlquist, 1987) to yield intermediate plasmids with the 55 This example describes the a cDNA 
,.DNA duplications of p ~ 3 ~ ~ 2  and p ~ 3 ~ ~ 3  respectively. RNA3 derivative which directs the expression of chloram- 
The small pstI-ClaI fragment of each plasmid was then phenicol acetyl transferase (CAT) activity under the tran- 
exchanged for the small PstI-ClaI fragment of pB3TP8 (to scription control of the BMV subgenomic promoter, wherein 
substitute a bacteriophage T7 promoter for the E- coli the expression of the subgenomic promoter-CAT gene COm- 
promoter for in vitro transcription) to yield pB3IC2 and 60 ~ l e x  is from a site On the RNA3 
pB3IC3. In two additional constructions the large EcoRI- The subgenomic promoter-CAT gene complex is cloned 
HincII fragment of pB3HS1 (French and Ahlquist, 1987) as a AvaI-PstI fragment of pB3CA42 (R. French et al. (1986) 
was ligated with the small AvaI-EcoRI fragment of pB3TP8 Science 23 1: 1294). After filling out the single-stranded ends 
or pB3IC4. The large BglII-EcoRI fragments of the resultant with Klenow DNA polymerase, this fragment is cloned into 
plasmids were ligated individually with the small BamHI- 65 the XbaI site of pB3TP7 after similar treatment to create 
EcoRI fragment of pB3BC1 to yield pB3IC5 and pB3IC6, flush ends; the resultant plasmid in which the orientation of 
respectively. the subgenomic promoter-CAT gene complex is the same as 
5,466,788 
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in the surrounding cDNA is called pB3-SGP. said (+) strand RNA virus further comprises an activating 
RNA transcripts are introduced into barley protoplasts as domain corresponding to the nucleotide sequence from a 
described in Example 2. CAT gene activity is measured as Bs tX  site to a BglII site of the cDNA corresponding to the 
described in French et al., 1986. RNA of FIG. 2, and wherein said activating domain is 
5 positioned 5' to said subgenomic core promoter sequence. 
EXAMPLE 4 2. The recombinant DNA molecule of claim 1 wherein 
said subgenomic core promoter is the subgenomic promoter 
Construction of pBMVSGP and Two-Stage Gene of brome mosaic virus. 
Expression Controlled by the BMV Subgenomic 3. A recombinant DNA molecule comprising the subge- 
Promoter 10 nomic promoter of claim 2 and further comprising a plant- 
This example describes the construction of a recombinant expressible gene under the regulatory control of said sub- 
DNA molecule containing the subgenomic promoter of genomic promoter. 
BMV and the bacterial chloramphenicol acetyltransferase 4. The recombinant DNA molecule of claim 2 wherein 
(CAT) gene, such that expression of the CAT gene is under said subgenomic promoter the 'Ore promoter 
the regulatory control of the subgenomic promoter. This Sequence from a Bgl' site to a site Of the 
molecule can be used to reduce the BMV subgenomic corresponding to the RNA Of 27 and further comprises 
promoter-dependent CAT gene into tissue by any the activating sequence a Bsm site to a Bgln site 
means known to the art. Treatment of the genetically modi- the cDNA corresponding to the RNA of FIG. 2, wherein said 
fied plant tissue by treating with BMV genomic to 20 activating domain is located no more than 95 nucleotides 
supply RNA- dependent RNApolymerase activity then turns 'pStream of a subgenomic start site. 
on the expression of the CAT gene under the control of the '. The DNA Of wherein 
subgenomic promoter. said subgenomic promoter comprises the core promoter 
sequence from a BglII site to a SalI site of the cDNA The fragment P~~~~~~ (R. French et al. corresponding to the RNA of FIG. 2, and farther comprises (1986) Science 231:1294) provides the subgenomic Pro- 25 the activating sequence from an AvaI site to a BglII site of 
moter-CAT gene combination. After repairing all single- the cDNA corresponding to the RNA of FIG. 2, wherein said 
stranded with K1enow DNA polymerase, this activating domain is located no more than 95 nucleotides fragment is inserted at the BarnHI site of pGA355+26 (G. 
upstream of a subgenomic transcription start site. An et al. (1986) Mol. Gen. Genet. 203:245). Restriction 6. The recombinant DNA molecule of claim 2 further 
'gests are performed to choose the product in 30 comprising a second copy of said subgenomic core promoter 
which that the PstI-end is adjacent to the nos promoter, a and a second copy of said activating domain, wherein said poln promoter; this recombinant is PBMVSGP. Thus, a second copy of said activating domain is positioned to 
primary directed the nos promoter be a (-1 said second copy of a subgenomic core promoter to form a 
strand with to the subgenomic promoter and the CAT second subgenomic promoter and wherein said second sub- 
coding region. There is no translation initiation site in the 35 genomic promoter is positioned within said artificially con- 
nos-derived portion of the primary transcript. 
structed recombinant DNA molecule to allow functioning of 
pBMVSGP is introduced into tobacco protoplasts using said second subgenomic promoter within an RNA copy of 
the technique of electroporation (M. Fromm et al. (1985) said DNA molecule. 
Proc. Natl. Acad. Sci. 82:5824). Primary (-) strand tran- 7. An artificially constructed recombinant DNA molecule 
scripts will be constitutively synthesized by Cellular RNA 40 comprising a subgenomic promoter, wherein said subge- 
polymerase II. nomic promoter comprises a nucleotide sequence from 
Subgenomic promoter-dependent expression of CAT is brome mosaic virus from a BstXI site to a SalI site of the 
accomplished by introducing BMV RNAs as the source of cDNA corresponding to the RNA of FIG. 2, and duplicate 
RNA-dependent RNA polymerase activity into the geneti- copies of an activating domain of brome mosaic virus, 
cally modified tobacco protoplasts, as described by L. Loe- 45 wherein said duplicate sequence is from an AvaI site to a 
sch-Fries et al. (1985) Virology 143:626. CAT enzymatic BgllI site of the cDNA corresponding to the RNA of FIG. 2, 
activity is measured as described (French et al. (1986)). wherein said duplicate activating domain sequence is 
We claim: located about 220 nucleotides upstream of a subgenomic 
1. An artificially constructed recombinant DNA molecule transcription start site, said subgenomic promoter further 
comprising the nucleotide sequence of a (+) strand plant 50 comprising a consensus sequence selected from the group 
RNA virus subgenomic core promoter selected from the consisting of AUCUAUGUU and sequences having a single 
group consisting of tobamoviruses, tobraviruses, bromovi- mismatch thereto, and said recombinant DNA molecule 
ruses, cucumoviruses and alfalfa mosaic virus, wherein said further comprising a plant-expressible gene under the regu- 
(+) strand RNA virus comprises a consensus sequence latory control of said subgenomic promoter. 
selected from the group consisting of AUCUAUGUU and 55 
sequences having a single mismatch thereto, and wherein * * * * * 

